Navigation Links
Jazz Pharmaceuticals Announces First Quarter 2011 Financial Results
Date:5/3/2011

ability of investors to compare our results from period to period.  Investors should note that adjusted net income and adjusted net income per diluted share, as used by Jazz Pharmaceuticals, may be calculated differently from, and therefore may not be directly comparable to, similarly titled measures used by our competitors and other companies.  Adjusted net income and adjusted net income per diluted share exclude from the comparable GAAP measures:  revenue related to upfront and milestone payments, amortization of intangible assets, stock-based compensation, and non-cash interest expense associated with a debt discount and debt issuance costs.

"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995This press release contains forward-looking statements, including, but not limited to, statements related to Jazz Pharmaceuticals’ commercial success, financial performance, growth potential and future financial performance, including 2011 financial guidance, and statements related to future product development.  These forward-looking statements are based on the company’s current expectations and inherently involve significant risks and uncertainties.  Jazz Pharmaceuticals' actual results and the timing of events could differ materially from those anticipated in such forward looking statements as a result of these risks and uncertainties, which include, without limitation, risks related to: Jazz Pharmaceuticals’ dependence on sales of Xyrem and its ability to increase sales of its Xyrem and Luvox CR products; competition, including potential generic competition; Jazz Pharmaceuticals’ dependence on single source suppliers and manufacturers; the ability of Jazz Pharmaceuticals to protect its intellectual property and defend its patents; regulatory risks; Jazz Pharmaceuticals’ cash flow and the sufficiency of its cash resources; and those risks detailed from time-to-time under the c
'/>"/>

SOURCE Jazz Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... Partnership to Fight Chronic Disease (PFCD) released a public opinion poll ... new study analyzing the impact of increased cost sharing on patient ... to educate policy makers and the public on the costs of ... how the Iowa healthcare exchange could be ...
(Date:1/23/2015)... BETHESDA, Md. , Jan. 23, 2015  Northwest Biotherapeutics, Inc. ... developing DCVax® personalized immune therapies for operable and inoperable solid ... will present at the 7 th Annual Phacilitate Immunotherapy ... NW Bio,s presentation at Phacilitate will take place on January ...
(Date:1/23/2015)... , Jan. 23, 2015 More than a third of ... of those with private insurance, filled a prescription for an ... report in this week,s Morbidity and Mortality Weekly Report (MMWR). ... providers to treat moderate to severe pain.  They are also ...
Breaking Medicine Technology:New research shows Iowa health exchange would benefit from improvements 2New research shows Iowa health exchange would benefit from improvements 3NW Bio To Present At The 7th Annual Phacilitate Immunotherapy Forum 2NW Bio To Present At The 7th Annual Phacilitate Immunotherapy Forum 3Opioid painkillers widely prescribed among reproductive age women 2Opioid painkillers widely prescribed among reproductive age women 3
... 2012 Ventana Medical Systems, Inc. ( Ventana ... now introducing a novel platform for special stains, ... customers, challenges with their current process, the new ... automation, baking through staining including deparaffinization, random batch ...
... DCTH ) announced today that the Company has ... Delcath Hepatic CHEMOSAT® Delivery system with the Instituto Oncologico Baselga ... CHEMOSAT program at the IOB will be led by Javier ... Melanoma Programs. Dr. Cortes is also the Head of the ...
Cached Medicine Technology:Ventana Introduces the BenchMark Special Stains Platform 2Ventana Introduces the BenchMark Special Stains Platform 3Delcath Announces Agreement with Instituto Oncologico Baselga for Launch of CHEMOSAT in Spain 2Delcath Announces Agreement with Instituto Oncologico Baselga for Launch of CHEMOSAT in Spain 3Delcath Announces Agreement with Instituto Oncologico Baselga for Launch of CHEMOSAT in Spain 4
(Date:1/22/2015)... January 22, 2015 Liberty University has received ... program from the Council for Accreditation of Counseling ... of Liberty’s Center for Counseling & Family Studies , ... of the university’s new School of Behavioral Sciences. Prior to ...
(Date:1/22/2015)... California (PRWEB) January 22, 2015 The City of ... at 10 a.m., to commemorate the 42nd anniversary of the Supreme ... States. , “It’s been 42 years since the Roe vs. Wade ... is still as present as ever,” said City of West Hollywood ...
(Date:1/22/2015)... Gabe’s Chemo Duck Program is pleased to announce the release ... for kids with cancer. The Chemo Duck App, available on iTunes ... enjoyable games to help children of all ages living with cancer ... keep kids entertained, educated and at ease while waiting for clinic ...
(Date:1/22/2015)... VogueQueen is a seasoned and trusted leader who consistently ... thrilled to have it lead the wedding dress industry into ... prom dresses for the global market. , “The CEO of ... he focuses on continuing the goal of operational excellence and ...
(Date:1/22/2015)... Angelweddingdress is a famous wedding dress company ... to follow it on Facebook, Twitter, and Pinterest. The fans ... Angelweddingdress draws a lottery every week. , Moreover, the company ... 2015. Click Angelweddingdress homepage for more information. ...
Breaking Medicine News(10 mins):Health News:Liberty University's Resident Master’s Counseling Program Receives CACREP Accreditation 2Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 2Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 3Health News:VogueQueen Unveils New Designs of Prom Dresses for 2015 2Health News:Angelweddingdress Invites Its Customers To Follow It On Facebook, Twitter, And Pinterest 2
... Washington, DC Most cancers arise from the epithelium, the ... come from connective tissue cells, like the bones. At ... full-court press to develop new therapies to treat osteosarcoma and ... adolescents and young adults. At the AACR 101st ...
... the health threat posed by Americans, over-consumption of sodium, experts ... Health (HSPH) and The Culinary Institute of America (CIA) called ... that maximize the enjoyment people derive from food. ... reduction as a critical public health priority, much as we ...
... evidence that popular computer games helped in any way ... of British researchers reports that popular brain-training computer games ... fact, the investigation, conducted by the Medical Research Council ... network, revealed that these brain games do little to ...
... by the Columbia Center for Children,s Environmental Health (CCCEH) ... exposure to pollutants can adversely affect children,s cognitive development ... York City (NYC) study. Researchers report ... hydrocarbons (PAHs) in Krakow had a significant reduction in ...
... ... babies. , ... April 20, 2010 -- Building on 175 years of expertise in the care for mothers ... new , , , , ,ePhilanthropy venture dedicated to supporting healthy moms, pregnancies and babies. ...
... U.S. panel says agency should cut levels slowly over next ... News) -- The U.S. Food and Drug Administration should take ... diet over the next decade, an expert panel advised Tuesday. ... independent agency created by Congress to research and advise the ...
Cached Medicine News:Health News:Lombardi research teams hone in on treatments for osteosarcoma and Ewing's sarcoma 2Health News:Lombardi research teams hone in on treatments for osteosarcoma and Ewing's sarcoma 3Health News:Lombardi research teams hone in on treatments for osteosarcoma and Ewing's sarcoma 4Health News:Lombardi research teams hone in on treatments for osteosarcoma and Ewing's sarcoma 5Health News:Experts call for accelerated national sodium reduction initiatives 2Health News:Experts call for accelerated national sodium reduction initiatives 3Health News:Experts call for accelerated national sodium reduction initiatives 4Health News:'Brain Games' Do Not Make You Smarter 2Health News:'Brain Games' Do Not Make You Smarter 3Health News:Children's cognitive ability can be affected by mother's exposure to urban air pollutants 2Health News:Brigham and Women's Hospital Launches Stork Fund 2Health News:Brigham and Women's Hospital Launches Stork Fund 3Health News:Experts Urge FDA to Lower Salt in American Diet 2Health News:Experts Urge FDA to Lower Salt in American Diet 3Health News:Experts Urge FDA to Lower Salt in American Diet 4
... Axiovert 200, the state of the ... has outstanding Zeiss optics with,the wide range ... optimized fluorescence as well as with an ... options, outstanding stability and unique ergonomically designed. ...
... the hallmark of these stereozoom fluorescent microscopes ... top (incident) circular 9W fluorescent ring light ... cool to the touch. Binocular and trinocular ... 44x zoom magnification or high-power 20x to ...
... first inverted microscope to take full advantage ... design enables optical input/output of light and ... and detector equipment. Extendable "Stratum Structure" configuration ... source and other attachments within the infinity ...
... IR/DIC video camera. Olympus wide array of high-quality ... quality and flexibility you need for an efficient ... real-time image of your specimen that can be ... You can even record movies when these easy-to-operate ...
Medicine Products: